PLA2R1 promoter methylation and leukaemic blast cell number were analysed in BM aspirates and PB samples of children with B-cell ALL at defined timepoints of the ALL treatment protocol (Fig. 2). Here, PLA2R1 is linked to acute lymphoblastic leukemia.